MapLight Therapeutics, Inc. (MPLT) Deep Dive Video
Summary
MapLight is a high-risk, high-upside CNS biotech where one schizophrenia readout could determine whether ML-007C-MA becomes a best-in-class muscarinic challenger or the company resets to early-stage pipeline value.